General Information of the Compound
| Compound ID |
CP0062351
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
42-548
Show/Hide
|
||||||||||||||||||
| Synonyms |
Diestet
(+-)-5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol
22232-71-9
5-(4-Chlorophenyl)-2,3-dihydro-5-hydroxy-5H-imidazo(2,1-a)isoindole
5-(4-Chlorophenyl)-2,3-dihydro-5-hydroxy-5H-imidazo[2,1-a]isoindole
5-(4-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol
5-(4-Chlorophenyl)-3,5-dihydro-2H-imidazo[2,1-a]isoindol-5-ol
5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol
5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol
5-p-Chlorophenyl-2,3-dihydro-5H-imidazo(2,1-a)isoindol-5-ol
5H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,3-dihydro
AN 448
AN 448;AN448
AN-448
BRN 0546547
CCRIS 3152
CHEMBL781
DEA No 1605
Dimagrir
EINECS 244-857-0
HSDB 3112
Magrilon
Mazanor
Mazanor (TN)
Mazildene
Mazindol
Mazindol (JAN/USP/INN)
Mazindol Medix Brand
Mazindol Novartis Brand
Mazindol Searle Brand
Mazindol Wyeth Brand
Mazindol [USAN:BAN:INN]
Mazindole
Mazindolum
Mazindolum [INN-Latin]
Medix Brand of Mazindol
Novartis Brand of Mazindol
S 42548
SA 42-548
SAH 42548
SANOREX (TN)
Sanjorex
Sanorex
Sanorex (TN)
Searle Brand of Mazindol
Solucaps
Terenac
Teronac
Teronak
Wyeth Brand of Mazindol
[3H]mazindol
mazindol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H13ClN2O
|
||||||||||||||||||
| Molecular Weight |
284.746
|
||||||||||||||||||
| Canonical SMILES |
OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZPXSCAKFGYXMGA-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
22232-71-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Cell-based Assay
Protein ID: PT03401, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Cell-based Assay
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound